Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Cash Flow Quality Index
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow Quality Index of 0.87x as of December 2024. Operating cash flow of CN¥142.23 Million is below net income of CN¥164.32 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Hunan Warrant Pharmaceutical Co. Ltd. A to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688799 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year earnings quality comparison for Hunan Warrant Pharmaceutical Co. Ltd. A. For live market cap and the full company financial profile, see Hunan Warrant Pharmaceutical Co. Ltd. A (688799) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.87x | CN¥142.23 Million | CN¥164.32 Million | ▼ -14.7% |
| 2023 | 1.01x | CN¥214.44 Million | CN¥211.37 Million | ▲ +19.2% |
| 2022 | 0.85x | CN¥155.65 Million | CN¥182.80 Million | ▲ +19.3% |
| 2021 | 0.71x | CN¥114.72 Million | CN¥160.76 Million | ▼ -1.1% |
| 2020 | 0.72x | CN¥104.66 Million | CN¥145.03 Million | ▼ -28.2% |
| 2019 | 1.01x | CN¥116.66 Million | CN¥116.01 Million | — |